Back to search

The importance of tamoxifen metabolism in tamoxifen-stimulated breast tumor growth

Data up to Jan 2025

Published1994
Citations129
References22

Total Citations Per Year

Abstract

References (22)

Systemic treatment of early breast cancer by hormonal, cytotoxic, or immune therapy

1992 • 2,084 citations

A potent specific pure antiestrogen with clinical potential.

1991 • 1,111 citations

Development of tamoxifen-stimulated growth of MCF-7 tumors in athymic mice after long-term antiestrogen administration.

1988 • 417 citations

Effect of estrogens and antiestrogens on growth of human breast cancer cells in athymic nude mice.

1985 • 396 citations

Inhibition of tamoxifen-stimulated growth of an MCF-7 tumor variant in athymic mice by novel steroidal antiestrogens.

1989 • 249 citations

Acquired Tamoxifen Resistance: Correlation With Reduced Breast Tumor Levels of Tamoxifen and Isomerization of Trans-4-Hydroxytamoxifen

1991 • 233 citations

Measurement of steroid hormone receptors in breast cancer patients on tamoxifen

1993 • 195 citations

Human breast cancer in the athymic nude mouse: Cystostatic effects of long-term antiestrogen therapy

1987 • 186 citations

Tamoxifen

1989 • 170 citations

Tamoxifen antiestrogens. A comparison of the activity, pharmacokinetics, and metabolic activation of the cis and trans isomers of tamoxifen

1982 • 169 citations

Tamoxifen and the isomers of 4-hydroxytamoxifen in tamoxifen-resistant tumors from breast cancer patients.

1992 • 144 citations

Multicenter phase II efficacy trial of toremifene in tamoxifen-refractory patients with advanced breast cancer.

1993 • 113 citations

Effects of antioestrogens on the proliferation of MCF-7 human breast cancer cells

1989 • 110 citations

Investigation of the Mechanism of Tamoxifen-Stimulated Breast Tumor Growth With Nonisomerizable Analogues of Tamoxifen and Metabolites

1993 • 92 citations

Identification of estrogenic tamoxifen metabolite(s) in tamoxifen-resistant human breast tumors.

1992 • 87 citations

Structure-function relationships of hydroxylated metabolites of tamoxifen that control the proliferation of estrogen-responsive T47D breast cancer cells in vitro.

1990 • 82 citations

Oestrogenic activity of tamoxifen and its metabolites on gene regulation and cell proliferation in MCF-7 breast cancer cells

1989 • 66 citations

Synthesis and estrogen receptor binding of 6,7-dihydro-8-phenyl-9-[4-[2-(dimethylamino)ethoxy]phenyl]-5H-benzocycloheptene, a nonisomerizable analog of tamoxifen. X-ray crystallographic studies

1986 • 50 citations

CURRENT CLINICAL ONCOLOGY

2003 • 44 citations

Nafoxidine–-an antiestrogen for the treatment of breast cancer

1976 • 43 citations

Nonisomerizable analogs of (Z)- and (E)-4-hydroxytamoxifen. Synthesis and endocrinological properties of substituted diphenylbenzocycloheptenes

1988 • 34 citations

Hormonal Treatment of Advanced Breast Cancer

1995 • 34 citations

Cited By (0)

No citing papers found in database

The importance of tamoxifen metabolism in tamoxifen-stimulated breast tumor growth (1994) – Cancer Chemotherapy and Pharmacology | Metascience Observatory Explorer